SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-010172
Filing Date
2019-02-14
Accepted
2019-02-14 16:30:42
Documents
1
Period of Report
2019-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3631
  Complete submission text file 0001209191-19-010172.txt   5192
Mailing Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Fund X, L.P. (Reporting) CIK: 0001628098 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38596 | Film No.: 19607073

Mailing Address 18 COMMERCE WAY WOBURN MA 01801
Business Address 18 COMMERCE WAY WOBURN MA 01801 781-995-2443
Replimune Group, Inc. (Issuer) CIK: 0001737953 (see all company filings)

IRS No.: 822082553 | State of Incorp.: MA | Fiscal Year End: 0331
SIC: 2836 Biological Products, (No Diagnostic Substances)